These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17120779)

  • 1. Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation.
    Mochida Y; Parisuthiman D; Yamauchi M
    Adv Exp Med Biol; 2006; 585():101-13. PubMed ID: 17120779
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J; Osses N; Brandan E
    J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of decorin and biglycan by cultured osteoblastic cells.
    Takagi M; Yamada T; Kamiya N; Kumagai T; Yamaguchi A
    Histochem J; 1999 Jun; 31(6):403-9. PubMed ID: 10462226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transforming growth factor-beta1 on the gene expression of decorin, biglycan, and alkaline phosphatase in osteoblast precursor cells and more differentiated osteoblast cells.
    Yamada T; Kamiya N; Harada D; Takagi M
    Histochem J; 1999 Oct; 31(10):687-94. PubMed ID: 10576418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
    Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
    J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.
    Chen XD; Fisher LW; Robey PG; Young MF
    FASEB J; 2004 Jun; 18(9):948-58. PubMed ID: 15173106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
    Behnam K; Murray SS; Brochmann EJ
    Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation.
    Lai CF; Cheng SL
    J Bone Miner Res; 2005 Feb; 20(2):330-40. PubMed ID: 15647827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling.
    Osyczka AM; Leboy PS
    Endocrinology; 2005 Aug; 146(8):3428-37. PubMed ID: 15905316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2.
    Lecanda F; Avioli LV; Cheng SL
    J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-2 induces differentiation of multipotent C3H10T1/2 cells into osteoblasts, chondrocytes, and adipocytes in vivo and in vitro.
    Date T; Doiguchi Y; Nobuta M; Shindo H
    J Orthop Sci; 2004; 9(5):503-8. PubMed ID: 15449126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation.
    Balint E; Lapointe D; Drissi H; van der Meijden C; Young DW; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    J Cell Biochem; 2003 May; 89(2):401-26. PubMed ID: 12704803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
    Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
    J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro.
    Suzawa M; Takeuchi Y; Fukumoto S; Kato S; Ueno N; Miyazono K; Matsumoto T; Fujita T
    Endocrinology; 1999 May; 140(5):2125-33. PubMed ID: 10218963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.